FDA-approved drugs that protect mammalian neurons from glucose toxicity slow aging dependent on cbp and protect against proteotoxicity.
FDA-approved drugs that protect mammalian neurons from glucose toxicity slow aging dependent on cbp and protect against proteotoxicity.
复制标题
DOI:
10.1371/journal.pone.0027762
复制
发表时间:
2011
期刊:
影响因子:
3.7
通讯作者:
Mobbs C
中科院分区:
文献类型:
--
作者:
Lublin A;Isoda F;Patel H;Yen K;Nguyen L;Hajje D;Schwartz M;Mobbs C
Screening a library of drugs with known safety profiles in humans yielded 30 drugs that reliably protected mammalian neurons against glucose toxicity. Subsequent screening demonstrated that 6 of these 30 drugs increase lifespan in C. elegans: caffeine, ciclopirox olamine, tannic acid, acetaminophen, bacitracin, and baicalein. Every drug significantly reduced the age-dependent acceleration of mortality rate. These protective effects were blocked by RNAi inhibition of cbp-1 in adults only, which also blocks protective effects of dietary restriction. Only 2 drugs, caffeine and tannic acid, exhibited a similar dependency on DAF-16. Caffeine, tannic acid, and bacitracin also reduced pathology in a transgenic model of proteotoxicity associated with Alzheimer's disease. These results further support a key role for glucose toxicity in driving age-related pathologies and for CBP-1 in protection against age-related pathologies. These results also provide novel lead compounds with known safety profiles in human for treatment of age-related diseases, including Alzheimer's disease and diabetic complications.
登录
查看更多内容
影响因子:
3.6
作者:
Cui, Lili;Zhang, Xiangjian;Du, Wei
通讯作者:
Du, Wei
影响因子:
56.9
作者:
JOHNSON, TE
通讯作者:
JOHNSON, TE
影响因子:
64.8
作者:
Bishop, Nicholas A.;Guarente, Leonard
通讯作者:
Guarente, Leonard
DOI:
10.1073/pnas.92.20.9368
发表时间:
1995-09-26
影响因子:
11.1
作者:
LINK, CD
通讯作者:
LINK, CD
影响因子:
29
作者:
Lee SJ;Murphy CT;Kenyon C
通讯作者:
Kenyon C